Evolution of troponin, C-reactive protein and eosinophil count with the onset of clozapine-induced myocarditis

Australian and New Zealand Journal of Psychiatry

Volumn 49, Issue 5, 2015, Pages 486-487

  Ronaldson, Kathlyn J ^a   Fitzgerald, Paul B ^b   Mcneil, John J ^a  

^a MONASH UNIVERSITY   (Australia)

^b Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLOZAPINE; TROPONIN; NEUROLEPTIC AGENT;

EOSINOPHIL COUNT; HUMAN; LETTER; MYOCARDITIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; CASE CONTROL STUDY; CHEMICALLY INDUCED; EOSINOPHIL; LEUKOCYTE COUNT; METABOLISM;

ANTIPSYCHOTIC AGENTS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CLOZAPINE; EOSINOPHILS; HUMANS; LEUKOCYTE COUNT; MYOCARDITIS; TROPONIN;

EID: 84930583777     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867414566871     Document Type: Letter

References (3)

1. Ronaldson KJ, Fitzgerald PB, Taylor AJ, et al. (2012) Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: A casecontrol study. Schizophrenia Research 141: 173-178.
2. Ronaldson KJ, Taylor AJ, Fitzgerald PB, et al. (2010) Diagnostic characteristics of clozapine induced myocarditis identified by an analysis of 38 cases and 47 controls. Journal of Clinical Psychiatry 71: 976-981.
3. Ronaldson KJ, Taylor AJ, Fitzgerald PB, et al. (2011) A new monitoring protocol for clozapine induced myocarditis based on an analysis of 75 cases and 94 controls. Australian and New Zealand Journal of Psychiatry 45: 458-465.